*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Relationship of Femoral Bone Density with Gender of Study to be Acquainted with the Prevalence of Regional Osteoporosis in Patients

Author: M. REDDY, M.K. VETRI KUMAR
Abstract: Worldwide, the quantity of hip fractures, the maximum essential osteoporotic hardship in the ageing, keeps to upsurge consistent with the getting old of the population. Bone mineral density (BMD) is the quantity of the minerals, in the main calcium and phosphorous, controlled insure extent of bone to identify osteoporosis. Low bone mineral density is a danger element for fractures. Although there are numerous danger elements affecting the threat of fragility fractures, low bone density, mass, and strength make a contribution to better fracture threat if falling. In fracture prevention, it is critical to enhance each bone fitness and bodily overall performance. Osteoporosis might also reason the patients to be incapacitated with lower back ache, loss of top, kyphosis, pneumonia, and pulmonary thromboembolism. The pattern size turned into determined by the use of a single proportional system using the pervasiveness price of osteoporosis in India. The pattern length turned into determined by means of the usage of a unmarried proportional components using the pervasiveness rate of osteoporosis in India. This research work proposes association of femoral bone density with gender of study to know the prevalence of regional osteoporosis in patients.
Keyword: World Health Organization, Bisphosphonates, Denosumab, DXA, Osteopenia and SD.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.215
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free